Search   
MSDS  : Sulfanilamide, N(sup 1)-2-pyrimidinyl-
CAS  : 68-35-9
SYNONYMS  : * A 306 * Adiazine * Benzenesulfonamide, 4-amino-N-2-pyrimidinyl- * Coco-Diazine * Cremodiazine * Debenal * Deltazina * Diazin * Di-Azo-Mul * Diazovit * Diazyl * Eskadiazine * Honey diazine * Lipo-Diazine * Lipo-Levazine * Liquadiazine * Microsulfon * Neazine * Pecta-diazine, suspension * Piridisir * Pyrimal * Pyrimidine, 2-sulfanilamido- * N(sup 1)-2-Pyrimidinyl-sulfanilamide * RP 2616 * Sanodiazine * SDA * S.N. 112 * Spofadrizine * Sterazine * Sulfadiazine * Sulfanilamide, N(sup 1)-2(1H)-pyrimidinylidene * 2-Sulfanilamidopyrimidin * Sulfanilamidopyrimidine * 2-Sulfanilylaminopyrimidine * Sulfapyrimidin * Sulfapyrimidine * 2-Sulfapyrimidine * Sulfazine * Sulphadiazine * Theradiazine
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : WP1925000
CHEMICAL NAME : Sulfanilamide, N(sup 1)-2-pyrimidinyl-
CAS REGISTRY NUMBER : 68-35-9
BEILSTEIN REFERENCE NO. : 0235192
REFERENCE : 5-25-10-00067 (Beilstein Handbook Reference)
LAST UPDATED : 199707
DATA ITEMS CITED : 20
MOLECULAR FORMULA : C10-H10-N4-O2-S
MOLECULAR WEIGHT : 250.30
WISWESSER LINE NOTATION : T6N CNJ BMSWR DZ
COMPOUND DESCRIPTOR : Drug
Reproductive Effector
Human
SYNONYMS/TRADE NAMES :
* A 306
* Adiazine
* Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-
* Coco-Diazine
* Cremodiazine
* Debenal
* Deltazina
* Diazin
* Di-Azo-Mul
* Diazovit
* Diazyl
* Eskadiazine
* Honey diazine
* Lipo-Diazine
* Lipo-Levazine
* Liquadiazine
* Microsulfon
* Neazine
* Pecta-diazine, suspension
* Piridisir
* Pyrimal
* Pyrimidine, 2-sulfanilamido-
* N(sup 1)-2-Pyrimidinyl-sulfanilamide
* RP 2616
* Sanodiazine
* SDA
* S.N. 112
* Spofadrizine
* Sterazine
* Sulfadiazine
* Sulfanilamide, N(sup 1)-2(1H)-pyrimidinylidene
* 2-Sulfanilamidopyrimidin
* Sulfanilamidopyrimidine
* 2-Sulfanilylaminopyrimidine
* Sulfapyrimidin
* Sulfapyrimidine
* 2-Sulfapyrimidine
* Sulfazine
* Sulphadiazine
* Theradiazine

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human - man
DOSE/DURATION : 229 mg/kg/8D-I
TOXIC EFFECTS :
Gastrointestinal - other changes
Kidney, Ureter, Bladder - urine volume decreased
REFERENCE :
IJMDAI Israel Journal of Medical Sciences. (POB 1435, Jerusalem 91013,
Israel) V.1- 1965- Volume(issue)/page/year: 6,561,1970

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Unreported
SPECIES OBSERVED : Human - child
DOSE/DURATION : 138 mg/kg
TOXIC EFFECTS :
Behavioral - general anesthetic
Kidney, Ureter, Bladder - urine volume decreased
Kidney, Ureter, Bladder - hematuria
REFERENCE :
PGMJAO Postgraduate Medical Journal. (Blackwell Scientific Pub. Ltd., POB
88, Oxford, UK) V.1- 1925- Volume(issue)/page/year: 53,103,1977

TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 446 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KLWOAZ Klinische Wochenscrift. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.1- 1922- Volume(issue)/page/year:
27,449,1949

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 880 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und
Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher
information, see NSAPCC. Volume(issue)/page/year: 211,367,1950

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 21,571,1971

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 750 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
29ZVAB "Handbook of Analytical Toxicology," Sunshine, I., ed., Cleveland,
OH, Chemical Rubber Co., 1969 Volume(issue)/page/year: -,109,1969

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo,
Japan) Volume(issue)/page/year: 6,386,1982

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 180 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems
Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010)
Volume(issue)/page/year: NX#03347

TYPE OF TEST : LD - Lethal dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : >5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 79,354,1943

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 91200 mg/kg/22W-C
TOXIC EFFECTS :
Kidney, Ureter, Bladder - other changes
Endocrine - thyroid weight (goiter)
Related to Chronic Data - death
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 79,354,1943

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 5250 mg/kg/2W-C
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure,
acute tubular necrosis)
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 81,17,1944

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 2640 mg/kg/30D-C
TOXIC EFFECTS :
Endocrine - other changes
Blood - changes in spleen
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - transaminases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 14,2856,1980

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 6 gm/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Specific Developmental Abnormalities - craniofacial
(including nose and tongue)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o
Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho,
Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher
information, see CGANE7. Volume(issue)/page/year: 13,7,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 6 gm/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
resorbed implants per total number of implants)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o
Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho,
Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher
information, see CGANE7. Volume(issue)/page/year: 13,7,1973

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 6 gm/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
Reproductive - Specific Developmental Abnormalities - craniofacial
(including nose and tongue)
REFERENCE :
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o
Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho,
Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher
information, see CGANE7. Volume(issue)/page/year: 13,17,1973

*** REVIEWS ***

TOXICOLOGY REVIEW
JMSHAO Journal of the Mount Sinai Hospital (New York). (New York, NY)
V.1-36, 1934-69. For publisher information, see MSJMAZ.
Volume(issue)/page/year: 10,343,1943

TOXICOLOGY REVIEW
ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For
publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966

*** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***

NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA :
NOHS - National Occupational Hazard Survey (1974)
NOHS Hazard Code - 80538
No. of Facilities: 1033 (estimated)
No. of Industries: 4
No. of Occupations: 9
No. of Employees: 5001 (estimated)

NOES - National Occupational Exposure Survey (1983)
NOES Hazard Code - 80538
No. of Facilities: 95 (estimated)
No. of Industries: 2
No. of Occupations: 20
No. of Employees: 2854 (estimated)
No. of Female Employees: 849 (estimated)

*** STATUS IN U.S. ***

EPA TSCA Section 8(b) CHEMICAL INVENTORY


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Sulfanilamide, N(sup 1)-methyl- 1709-52-0
Sulfanilamide, N'-(5-methyl-3-isoxazolyl)- 723-46-6
Sulfanilamide, N(sup1)-(2-methyl-6-propoxy-4-pirimidinyl)-, sodium salt 723-46-6
Sulfanilamide, N(sup1)-(6-methyl-2-propyl-4-pyrimidinyl)-, sodium salt 723-46-6
Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)- 127-79-7
Sulfanilamide, N(sup 1)-(5-methyl-2-pyrimidinyl)- 599-88-2
Sulfanilamide, N(sup 1)-(4-methyl-2-pyrimidinyl)-,monosodium salt 127-58-2
Sulfanilamide, N(sup1)-(4-methyl-2-pyrimidinyl)-N(sup 1)-(2-(5-tetrazolyl)ethyl)- 69518-43-0
Sulfanilamide, N(sup1)-(5-methyl-1,3,4-thiadiazol-2-yl)- 144-82-1
Sulfanilamide, N(sup1)-(5-methyl-1,3,4-thiadiazol-2-yl)-, monosodium salt 58944-03-9
Styrene, alpha-nitro- 5468-44-0
Sulfanilamide, N(sup 1)-(4-methyl-2-thiazolyl)- 515-59-3
Sulfanilamide, N(sup 1)-(4-methyl-2-thiazolyl)-,sodium salt 58944-02-8
Sulfanilamide, N(sup1)-(4-methyl-6-(trifluoromethyl)-2-pyrimidinyl)- 6190-24-5
Sulfanilamide monohydrochloride 6101-31-1
Sulfanilamide, monosodium salt 10103-15-8
Sulfanilamide, N(sup 1)-(2-morpholinoethyl)- 1784-16-3
Sulfanilamide, N(sup 1)-(1-phenylpyrazol-5-yl)-,sodium salt 1784-16-3
Sulfanilamide, N(sup 1)-(4-phenyl-2-thiazolyl)-,sodium salt 63979-88-4
Sulfanilamide, N(sup 1)-(2-propyl-4-pyrimidinyl)-,sodium salt 63979-88-4
Sulfanilamide, N(sup 1)-(2-pyrazinyl)-, monosodiumsalt 63979-88-4
Styrene, beta-nitro- 102-96-5
Sulfanilamide, N(sup 1)-2-pyridyl-, 1-oxide 19250-24-9
Sulfanilamide, N(sup 1)-(2-pyridyl)-N(sup1)-(2-(5-tetrazolyl)ethyl)- 69518-41-8
Sulfanilamide, N(sup 1)-2-pyrimidinyl- 68-35-9
Sulfanilamide, N(sup 1)-2-pyrimidinyl-,monosilver(1+) salt 22199-08-2
Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosodiumsalt 547-32-0
Sulfanilamide, N(sup 1)-(2-pyrimidinyl)-N(sup1)-(2-(5-tetrazolyl)ethyl)- 69518-42-9
Sulfanilamide, N(sup 1)-2-quinoxalinyl- 59-40-5
Sulfanilamide, N(sup 1)-(2-(5-tetrazolyl)ethyl)-N(sup1)-(2-thiazolyl)- 69518-36-1
Sulfanilamide, N(sup 1)-2-thiazolyl- 72-14-0
Sulfanilamide, N(sup 1)-2-thiazolyl-, monosodium salt 144-74-1
Styrene, beta-nitro-, (E)- 5153-67-3
Sulfanilamide, N(sup 1)-2-thiazolyl-, 3-oxide 19250-30-7
Sulfanilamide, N(sup 1)-(2-thienyl)-, monosodium salt 102395-93-7
Sulfanilamide, N(sup 4),N(sup 4')-thiodi- 69226-52-4
Sulfanilanilide, N(sup 1)-((trichloromethyl)thio)- 69226-52-4
Sulfanilanilide, 4'-(9-acridinylamino)- 57164-91-7
Sulfanilanilide, 4'-(dimethylsulfamoyl)- 515-67-3
Sulfanilanilide, 4'-fluoro- 1494-85-5
p-Sulfanilanisidide, 2'-amino- 1494-85-5
p-Sulfanilanisidide, 2'-amino-, sodium salt 1494-85-5
Sulfanilic acid 121-57-3
Styrene, p-nitro- 100-13-0
Sulfanilic acid, N-acetyl-, 2-pentyl ester 23531-31-9
Sulfanilic acid, N-(amidinoamidino)- 6405-80-7
Sulfanilic acid, N-(amidinoamidino)-, hydrochloride 6405-80-7
Sulfanilic acid, N-(amidinocarbamoyl)-, hydrochloride 73927-06-7
Sulfanilic acid, compd. with 2-aminoethanol (11) 15730-83-3
Sulfanilic acid, 2-(diethylamino)ethyl ester 15730-83-3

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net